Injectable Drug Delivery – Devices Focus
Issue No #75
May 8th, 2017
Inside the magazine
SAFEGUARDING USER NEEDS: THE LONG-TERM LEGACY OF SHL’S PATIENT-CENTRIC DESIGNS
Jochen Ratjen talks about his personal experiences, what patient-centricity means to SHL, and how SHL’s designs are moving ahead with the changing trends.
Bjørn Knud Andersen
FAST-TO-MARKET LARGE VOLUME INJECTOR FOR SELF-ADMINISTRATION
In response to a set of very specific device objectives Bjørn Knud Andersen and Bjarne Sørensen present an electronic, connected large-volume injector concept for self-administration as the ideal solution.
CONTINUOUS GROWTH & INNOVATION IN COMBINATION PRODUCT MARKET PRESENTS CHALLENGES & OPPORTUNITIES
Paul Sullivan describes how smart, error-detecting training devices that are true to the form and function of the actual device deliver the most promising impact on adherence and compliance for patient self-injection.
NEEDLE-FREE JET INJECTION IN WORKPLACE INFLUENZA CLINICS
Tara Miller, Chris Galloway, and William E Gannon Jr evaluate an unmet need for increasing immunisation coverage in workplace influenza clinics by offering needle-free injection technology.
Joël Cotten discusses the importance of sterile transfer in parenteral combination product manufacturing and Aptar Pharma’s gamma sterilisation suitable ready-to-use delivery device components.
YPSODOSE WEARABLE DEVICE FOR THE LARGE-VOLUME INJECTION OF BIOLOGICS
Ian Thompson describes self-injection device trends for larger injection volumes and introduces YpsoDose, a new prefilled large-volume wearable injector being developed by Ypsomed Delivery Systems.
Dr Iulia Karlsson
INJECTABLE DRUG DELIVERY: DEVICES MEET NEXT-GENERATION FORMULATIONS
Iulia Karlsson, discusses a new technology called BeloGal which allows drugs to be delivered in high doses to the right organ and avoids the problems of low water solubility that hamper many modern formulations.
ADJUSTING & CONTROLLING INJECTION SPEED BY DESIGN: IMPACT ON PAIN PERCEPTION
Isabell Delcroix and Pascal Dugand describe a study of the multi-award-winning Safelia
auto-injector platform, which showed how varying and slowing injection speed could reduce pain perception.
TONY BRATT, NORDIC PHARMA
Tony Bratt discusses Nordic Pharma’s specialised market focused business model and how he believes drug delivery systems, in particular the platform device concept, can play an important role in this niche product field.
AUTO-INJECTOR DESIGN: MANAGING DRUG TEMPERATURE VARIATIONS
Jake Cowperthwaite examines the impact of environmental and drug temperature variation on auto-injector performance and describes techniques for managing this variation on modern auto-injectors.
BUILDING BRIDGES FROM DRUGS TO PATIENTS: USABILITY & HUMAN FACTORS
Nicolas Sandoz describes Sensile Medical’s approach to ensuring it takes usability and human factors into account during the development of its devices, in particular for subcutaneous delivery.
West Pharmaceutical Services
DRUG CONTAINMENT & DELIVERY INNOVATION
Chris Henshall discusses how West's SmartDose platform considers the interface between drug, device and patient and how it offers an easy-to-use, reliable and integrated system for managing self-injection.
This website uses functional cookies (but not advertising cookies). View our
Privacy & Cookies Policy